(S)-2-Acetamido-5-amino-5-oxopentanoic acid, 95.0%, 100g

2-(1-Methyl-1H-benzo[d]imidazol-2-yl)acetonitrile, 95.0%, 1g

2-AMINO-3-BROMO-4-FLUOROBENZOIC ACID, 95%, 1g

(3aR,4S,6R,6aS)-6-(7-chloro-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-ol, 98%, 10mg

5-((1,4-Diazepan-1-yl)sulfonyl)isoquinolin-1(2H)-one, 95.0%, 25mg

Butyl 4-Hydroxybenzoate>99.0%(GC)(T)25g

Undecanophenone>98.0%(GC)500g

6-(4-Bromophenyl)-4-chloro-thieno[3,2-d]pyrimidine, 97%, 100mg

Agar de prueba de ADNasa

2-(4-Aminopiperidin-1-yl)ethan-1-ol, 98%, 250mg

2,4-Dichloro-6-methyl-5-pyrimidinecarboxaldehyde, 97%, 1g

(2-chlorophenyl)(4-fluorophenyl)methanone, 98.0%, 1g

Matraces aforados clase B transparente, 250 ml, 19/26, 2 Unidad(es)